Autolus Therapeutics
Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer
763 employees · est. 2014 · London, United Kingdom
Bastion Therapeutics
Creating a future where inflammatory disorders are curable
6 employees · est. 2018 · London, United Kingdom
Autolus Therapeutics is the older company (2014 vs 2018); Autolus Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Autolus Therapeutics | Bastion Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2014 older | 2018 |
| Headquarters | ||
| Headquarters | London, United Kingdom | London, United Kingdom |
| Employees | ||
| Employees | 763 larger | 6 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $1.07B | $840.00K |
| Funding Rounds | ||
| Funding Rounds | 10 | 1 |
| Services | ||
| Services | Development of autologous T cell therapies, Advanced cell programming, Manufacturing of T cells, Clinical trial management, Pipeline products for cancer and autoimmune diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with cancer and autoimmune diseases, Healthcare professionals, Investors interested in biotech innovations, Research institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | CAR T Cell Therapy, T Cell Programming, Cancer Treatment, Autologous T Cell Therapies, Next-generation Therapies, Obe-cel (obecabtagene Autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7, AUTO8, Autoimmune Disease Treatment, Biopharmaceuticals, Therapeutic Pipeline | Treg Cell Therapies, Inflammatory Disorders, Preclinical Stage, Immune Modulation, GRIT™ Platform Technology, Novel Therapies, Cell Engineering, Immune System Enhancement, Life Sciences, Therapeutic Development, Biomedical Innovation |
| Website | ||
| Website | autolus.com | bastion-tx.com |
About Autolus Therapeutics
Autolus Therapeutics, founded in 2014, is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries. Based in the United Kingdom, the company is renowned for its innovative approach towards cancer treatment, with a clear focus on developing precisely targeted and highly con...
About Bastion Therapeutics
Bastion Therapeutics, founded in 2018 and headquartered in the United Kingdom, is a preclinical stage biotech company with a compelling vision: Creating a future where inflammatory disorders are curable. Focused on developing innovative Treg cell therapies, the company targets the vast unmet clinica...
We will tell you when either one moves
BounceWatch watches Autolus Therapeutics and Bastion Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Autolus Therapeutics and Bastion Therapeutics — by email.
Frequently Asked Questions
Compare Autolus Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Autolus Therapeutics on 1 Apr 2026, and Bastion Therapeutics on 5 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.